David Floyd, Group President of Orthopaedics at Stryker, will retire on June 30, 2019. Until then, he will remain Group President and Advisor to Kevin Lobo, Chief Executive Officer.
Mr. Floyd began his orthopaedic career at Zimmer after graduating from college. He joined Stryker in 2012 after 25 years in medical technology, including leadership roles at Abbott Spine, AxioMed, Centerpulse (Sulzer), DePuy Orthopaedics and OrthoLogic. He also served a term as Chief Executive Officer of OrthoWorx in Warsaw, Indiana and has been a board member of NN, Inc., since 2016.
As head of Stryker Orthopaedics, he has overseen a number of acquisitions from 2013 to today–most notably Mako Surgical, and also Instratek, Small Bone Innovations and Stanmore Implants.
Responsibility for all operating business and regions will now fall to Timothy Scannell, who assumes the title of President and Chief Operating Officer as of August 2018.
Stryker is adopting a new commercial leadership structure with two new Group Presidents. J. Andrew Pierce is appointed Group President of MedSurg and Spencer Stiles as Group President of Instruments, Neurotechnology and Spine.
Mr. Scannell began his career with Stryker in 1990 and served in roles of increasing responsibility, most recently leading MedSurg and Neurotechnology divisions. Mr. Pierce and Mr. Stiles have both been with Stryker since 2008.
David Floyd, Group President of Orthopaedics at Stryker, will retire on June 30, 2019. Until then, he will remain Group President and Advisor to Kevin Lobo, Chief Executive Officer.
Mr. Floyd began his orthopaedic career at Zimmer after graduating from college. He joined Stryker in 2012 after 25 years in medical technology, including...
David Floyd, Group President of Orthopaedics at Stryker, will retire on June 30, 2019. Until then, he will remain Group President and Advisor to Kevin Lobo, Chief Executive Officer.
Mr. Floyd began his orthopaedic career at Zimmer after graduating from college. He joined Stryker in 2012 after 25 years in medical technology, including leadership roles at Abbott Spine, AxioMed, Centerpulse (Sulzer), DePuy Orthopaedics and OrthoLogic. He also served a term as Chief Executive Officer of OrthoWorx in Warsaw, Indiana and has been a board member of NN, Inc., since 2016.
As head of Stryker Orthopaedics, he has overseen a number of acquisitions from 2013 to today–most notably Mako Surgical, and also Instratek, Small Bone Innovations and Stanmore Implants.
Responsibility for all operating business and regions will now fall to Timothy Scannell, who assumes the title of President and Chief Operating Officer as of August 2018.
Stryker is adopting a new commercial leadership structure with two new Group Presidents. J. Andrew Pierce is appointed Group President of MedSurg and Spencer Stiles as Group President of Instruments, Neurotechnology and Spine.
Mr. Scannell began his career with Stryker in 1990 and served in roles of increasing responsibility, most recently leading MedSurg and Neurotechnology divisions. Mr. Pierce and Mr. Stiles have both been with Stryker since 2008.
Copy to clipboard 
